These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10444360

  • 1. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells.
    Nagaraju K, Raben N, Villalba ML, Danning C, Loeffler LA, Lee E, Tresser N, Abati A, Fetsch P, Plotz PH.
    Clin Immunol; 1999 Aug; 92(2):161-9. PubMed ID: 10444360
    [Abstract] [Full Text] [Related]

  • 2. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions.
    Behrens L, Kerschensteiner M, Misgeld T, Goebels N, Wekerle H, Hohlfeld R.
    J Immunol; 1998 Dec 01; 161(11):5943-51. PubMed ID: 9834075
    [Abstract] [Full Text] [Related]

  • 3. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue.
    Vyth-Dreese FA, Dellemijn TA, Majoor D, de Jong D.
    Eur J Immunol; 1995 Nov 01; 25(11):3023-9. PubMed ID: 7489738
    [Abstract] [Full Text] [Related]

  • 4. Costimulatory molecules in the developing human gastrointestinal tract: a pathway for fetal allergen priming.
    Jones CA, Vance GH, Power LL, Pender SL, Macdonald TT, Warner JO.
    J Allergy Clin Immunol; 2001 Aug 01; 108(2):235-41. PubMed ID: 11496240
    [Abstract] [Full Text] [Related]

  • 5. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
    Fasth AE, Dastmalchi M, Rahbar A, Salomonsson S, Pandya JM, Lindroos E, Nennesmo I, Malmberg KJ, Söderberg-Nauclér C, Trollmo C, Lundberg IE, Malmström V.
    J Immunol; 2009 Oct 01; 183(7):4792-9. PubMed ID: 19752224
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE.
    Ann Rheum Dis; 2007 Oct 01; 66(10):1276-83. PubMed ID: 17277004
    [Abstract] [Full Text] [Related]

  • 8. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
    Murata K, Dalakas MC.
    Am J Pathol; 1999 Aug 01; 155(2):453-60. PubMed ID: 10433938
    [Abstract] [Full Text] [Related]

  • 9. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
    Battaglia E, Biancone L, Resegotti A, Emanuelli G, Fronda GR, Camussi G.
    Am J Gastroenterol; 1999 Nov 01; 94(11):3279-84. PubMed ID: 10566730
    [Abstract] [Full Text] [Related]

  • 10. NK cell triggering by the human costimulatory molecules CD80 and CD86.
    Wilson JL, Charo J, Martín-Fontecha A, Dellabona P, Casorati G, Chambers BJ, Kiessling R, Bejarano MT, Ljunggren HG.
    J Immunol; 1999 Oct 15; 163(8):4207-12. PubMed ID: 10510357
    [Abstract] [Full Text] [Related]

  • 11. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
    Saito K, Sakurai J, Ohata J, Kohsaka T, Hashimoto H, Okumura K, Abe R, Azuma M.
    J Immunol; 1998 May 01; 160(9):4225-31. PubMed ID: 9574523
    [Abstract] [Full Text] [Related]

  • 12. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
    Greenfield EA, Howard E, Paradis T, Nguyen K, Benazzo F, McLean P, Höllsberg P, Davis G, Hafler DA, Sharpe AH, Freeman GJ, Kuchroo VK.
    J Immunol; 1997 Mar 01; 158(5):2025-34. PubMed ID: 9036945
    [Abstract] [Full Text] [Related]

  • 13. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
    Sugiura T, Kawaguchi Y, Harigai M, Takagi K, Ohta S, Fukasawa C, Hara M, Kamatani N.
    J Immunol; 2000 Jun 15; 164(12):6593-600. PubMed ID: 10843719
    [Abstract] [Full Text] [Related]

  • 14. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
    Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SD.
    J Immunol; 1997 Jan 15; 158(2):614-21. PubMed ID: 8992975
    [Abstract] [Full Text] [Related]

  • 15. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.
    Wiendl H, Mitsdoerffer M, Schneider D, Chen L, Lochmüller H, Melms A, Weller M.
    FASEB J; 2003 Oct 15; 17(13):1892-4. PubMed ID: 12923066
    [Abstract] [Full Text] [Related]

  • 16. Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM).
    Cid MC, Grau JM, Casademont J, Tobías E, Picazo A, Coll-Vinent B, Esparza J, Pedrol E, Urbano-Márquez A.
    Clin Exp Immunol; 1996 Jun 15; 104(3):467-73. PubMed ID: 9099932
    [Abstract] [Full Text] [Related]

  • 17. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD, Starling GC, Williams LA, Hock BD, Hart DN.
    Eur J Immunol; 1995 Jul 15; 25(7):2064-8. PubMed ID: 7542604
    [Abstract] [Full Text] [Related]

  • 18. Interactions of CD80 and CD86 with CD28 and CTLA4.
    Ellis JH, Burden MN, Vinogradov DV, Linge C, Crowe JS.
    J Immunol; 1996 Apr 15; 156(8):2700-9. PubMed ID: 8609386
    [Abstract] [Full Text] [Related]

  • 19. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.
    Dorph C, Englund P, Nennesmo I, Lundberg IE.
    Ann Rheum Dis; 2006 Dec 15; 65(12):1565-71. PubMed ID: 16831829
    [Abstract] [Full Text] [Related]

  • 20. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].
    Hiruma S, Ohtsuka K, Satou T, Furuta T, Kimura M, Hashimoto S.
    Rinsho Byori; 1998 Feb 15; 46(2):168-75. PubMed ID: 9528342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.